Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,127 | 702 | 99.7% |
| Education | $37.11 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,454 | 103 | $0 (2024) |
| Amgen Inc. | $1,416 | 70 | $0 (2024) |
| ABBVIE INC. | $907.07 | 71 | $0 (2024) |
| Novo Nordisk Inc | $864.49 | 59 | $0 (2024) |
| Lilly USA, LLC | $787.12 | 54 | $0 (2024) |
| Shire North American Group Inc | $493.41 | 25 | $0 (2019) |
| Amarin Pharma Inc. | $443.04 | 27 | $0 (2022) |
| PFIZER INC. | $328.77 | 21 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $292.91 | 23 | $0 (2021) |
| Esperion Therapeutics, Inc. | $290.90 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,710 | 97 | AstraZeneca Pharmaceuticals LP ($298.38) |
| 2023 | $1,473 | 84 | Lilly USA, LLC ($227.61) |
| 2022 | $1,409 | 81 | Amgen Inc. ($232.55) |
| 2021 | $1,393 | 87 | Amgen Inc. ($342.16) |
| 2020 | $804.92 | 53 | AstraZeneca Pharmaceuticals LP ($161.31) |
| 2019 | $1,166 | 75 | AstraZeneca Pharmaceuticals LP ($217.98) |
| 2018 | $1,548 | 102 | Shire North American Group Inc ($261.37) |
| 2017 | $1,661 | 128 | AstraZeneca Pharmaceuticals LP ($244.99) |
All Payment Transactions
707 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: ADHD | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: VACCINE | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Oncology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: ADHD | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: VACCINES | ||||||
| 09/16/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: ADHD | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 805 | 1,086 | $181,444 | $73,258 |
| 2022 | 15 | 751 | 1,029 | $183,087 | $73,025 |
| 2021 | 17 | 814 | 1,060 | $179,737 | $69,393 |
| 2020 | 15 | 662 | 972 | $139,442 | $50,288 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 328 | $85,280 | $29,438 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 254 | $44,958 | $16,595 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $19,530 | $11,525 | 59.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 29 | 29 | $6,090 | $4,596 | 75.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 21 | 21 | $4,620 | $3,335 | 72.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 14 | 14 | $2,856 | $1,700 | 59.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 36 | 38 | $2,508 | $1,316 | 52.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 33 | 76 | $5,092 | $1,233 | 24.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $900.36 | $882.32 | 98.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 42 | 42 | $1,932 | $852.43 | 44.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 39 | 42 | $2,184 | $712.00 | 32.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 37 | $3,515 | $405.98 | 11.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $285.48 | $279.76 | 98.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 15 | $1,005 | $243.00 | 24.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 33 | 43 | $688.00 | $144.07 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 378 | $98,280 | $33,590 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 110 | 110 | $23,100 | $13,878 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 211 | $37,347 | $13,668 | 36.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 19 | 19 | $4,180 | $3,044 | 72.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $2,940 | $2,258 | 76.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $3,060 | $1,971 | 64.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 30 | 32 | $2,112 | $1,116 | 52.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 23 | 48 | $3,216 | $782.14 | 24.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 36 | 42 | $2,184 | $664.37 | 30.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $570.96 | $559.52 | 98.0% |
About Dr. Paul Ellis, MD
Dr. Paul Ellis, MD is a Family Medicine healthcare provider based in Johns Creek, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740297811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Ellis, MD has received a total of $11,164 in payments from pharmaceutical and medical device companies, with $1,710 received in 2024. These payments were reported across 707 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($11,127).
As a Medicare-enrolled provider, Ellis has provided services to 3,032 Medicare beneficiaries, totaling 4,147 services with total Medicare billing of $265,964. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Johns Creek, GA
- Active Since 08/02/2006
- Last Updated 05/05/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1740297811
Products in Payments
- FARXIGA (Drug) $1,155
- Aimovig (Biological) $837.62
- VYVANSE (Drug) $449.31
- Vascepa (Drug) $443.04
- JARDIANCE (Drug) $442.28
- MOUNJARO (Drug) $309.77
- Ozempic (Drug) $297.33
- Livalo (Drug) $292.91
- NEXLETOL (Drug) $290.90
- Prolia (Biological) $285.90
- UBRELVY (Drug) $250.53
- MYDAYIS (Drug) $203.87
- Cologuard Collection Kit (Device) $191.48
- VRAYLAR (Drug) $190.78
- Dayvigo (Drug) $189.39
- Androgel (Drug) $185.07
- QELBREE (Drug) $181.82
- Otezla (Drug) $180.96
- AIRSUPRA (Drug) $175.02
- Xelstrym (Drug) $171.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Johns Creek
Tanya Pandya, D.o., M.b.a, D.O., M.B.A
Family Medicine — Payments: $11,737
Dr. Lisa Culpepper, Md, MD
Family Medicine — Payments: $7,450
Dr. Nancy Mcintyre, D.o, D.O
Family Medicine — Payments: $7,004
Dr. Karen Duvall, D.o, D.O
Family Medicine — Payments: $4,920
Christian-Jevon Bramwell, Md, MD
Family Medicine — Payments: $3,751
Dr. Arwyn Raina, M.d, M.D
Family Medicine — Payments: $1,675